Insights

Global Partnerships Recent distribution and collaboration agreements across Europe, Korea, Malaysia, India and Australia indicate rising regional demand for Quantoom’s Ntensify and end-to-end RNA manufacturing solutions. Use these partnerships as springboards to engage local biotechs, CROs, and research institutions seeking turnkey RNA production and LNP formulation.

Integrated Platform Quantoom offers an integrated RNA stack—Ncode for design, Ntensify for production, and Ncapsulate for LNP formulation—enabling a single supplier for vaccine and therapeutic programs and creating upsell opportunities for both development-stage and manufacturing-scale customers.

Asia Expansion The company’s active expansion into India, Korea, and Malaysia signals strong APAC demand; prioritize regional distributors, contract manufacturers, and research centers that can adopt Ntensify mano or mini for scalable RNA production and purification.

Academic Uptake Engagement with the University of Western Australia RNA Innovation Foundry demonstrates appetite in academia for Quantoom’s rapid RNA production tools, offering a channel to supply Ntensify mini and related solutions for cutting-edge research and early-stage programs.

Growth Opportunities A growing partner network and expanding client base provide cross-selling potential across Ntensify mano and mini, Ncode optimization, and strategic R&D partnerships to accelerate mRNA and saRNA vaccine and therapeutic programs.

Quantoom Biosciences Tech Stack

Quantoom Biosciences uses 8 technology products and services including HubSpot Analytics, LiteSpeed Cache, Cloudflare, and more. Explore Quantoom Biosciences's tech stack below.

  • HubSpot Analytics
    Analytics
  • LiteSpeed Cache
    Caching
  • Cloudflare
    Content Management System
  • Open Graph
    Content Management System
  • DocuSign
    Miscellaneous
  • R Project
    Programming Languages
  • Apache HTTP Server
    Web Servers
  • LiteSpeed
    Web Servers

Media & News

Quantoom Biosciences's Email Address Formats

Quantoom Biosciences uses at least 1 format(s):
Quantoom Biosciences Email FormatsExamplePercentage
F.Last@quantoom.comJ.Doe@quantoom.com
69%
First.Last@quantoom.comJohn.Doe@quantoom.com
31%

Frequently Asked Questions

What is Quantoom Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Quantoom Biosciences's official website is quantoom.com and has social profiles on LinkedIn.

What is Quantoom Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Quantoom Biosciences's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Quantoom Biosciences have currently?

Minus sign iconPlus sign icon
As of July 2026, Quantoom Biosciences has approximately 60 employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Ceo: J. C.Chief Operating Officer: R. T.Chief Financial Officer: C. P.. Explore Quantoom Biosciences's employee directory with LeadIQ.

What industry does Quantoom Biosciences belong to?

Minus sign iconPlus sign icon
Quantoom Biosciences operates in the Biotechnology Research industry.

What technology does Quantoom Biosciences use?

Minus sign iconPlus sign icon
Quantoom Biosciences's tech stack includes HubSpot AnalyticsLiteSpeed CacheCloudflareOpen GraphDocuSignR ProjectApache HTTP ServerLiteSpeed.

What is Quantoom Biosciences's email format?

Minus sign iconPlus sign icon
Quantoom Biosciences's email format typically follows the pattern of F.Last@quantoom.com. Find more Quantoom Biosciences email formats with LeadIQ.

When was Quantoom Biosciences founded?

Minus sign iconPlus sign icon
Quantoom Biosciences was founded in 2021.
Quantoom Biosciences logo

Quantoom Biosciences

Biotechnology ResearchWallonia, Belgium51-200 Employees

Quantoom Biosciences is a biotech company that provides end-to-end RNA solutions for developing mRNA- and saRNA-based vaccines and therapeutics. Its platform combines sequence design, RNA production, and RNA-LNP formulation to enable the conversion of antigens into workable drug products, with an emphasis on scalable, integrated manufacturing. The company also offers enabling services such as strategic R&D partnerships and sequence optimization to support its partners throughout the development process.
Headquartered in Nivelles, Belgium, Quantoom operates within the biotechnology research sector and serves customers across the life sciences field, including academic institutions and industry partners seeking turnkey RNA production and formulation capabilities. Since its launch in 2023, the firm has expanded its global reach through partnerships and distribution agreements intended to broaden access to its Ntensify solutions for RNA production and purification in additional regions.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Quantoom Biosciences's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Quantoom Biosciences's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.